Newsstand Menu

Discovering how a new leukemia drug undermines cancer cells

Unassuming and “pathetic” protein proves lynchpin in a new cancer drug’s therapeutic action.
Adaptor protein NSD3-short helps researchers explain anti-leukemia drug’s powerful effects.

Feat. CSHL Associate Prof. Christopher Vakoc, MD, PhD

More Videos